Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $3.87 | Prev. Close $3.77 | Circuit Range N/A |
Day Range $3.87 - $3.87 | Year Range $3.39 - $52.80 | Volume 100 |
Average Traded $3.87 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Nov-25 | $3.77 | $3.77 | +0.27% |
04-Nov-25 | $3.81 | $3.76 | -14.55% |
28-Oct-25 | $4.40 | $4.40 | +10.83% |
23-Oct-25 | $4.12 | $3.97 | -10.18% |
20-Oct-25 | $4.21 | $4.42 | -1.12% |
16-Oct-25 | $4.48 | $4.47 | +0.90% |
15-Oct-25 | $4.50 | $4.43 | -0.89% |